Other
Pilot Study
0
Pipeline Programs↗
26
Active Trials↗
34
Companies Involved↗
Pilot Study is an early-stage landscape with 0 programs across 34 companies. The most active players are GSK, Oxford Pharmascience Ltd, Orion Corporation, Orion Pharma.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Approved
Phase 3
Phase 2
Phase 1
Preclinical
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Pipeline
Programs by Phase
No pipeline programs currently tracked for this disease.
Analysis
Trial Status
333
clinical trials
Completed223 · 67%
Terminated35 · 11%
Unknown status29 · 9%
Withdrawn20 · 6%
Recruiting14 · 4%
Active, not recruiting6 · 2%
Other6 · 2%
Clinical Trials
Trial Activity
333 trials
Pilot Study for Detection of PSMA-Low CRPC-NE Tumors With Fluciclovine PET/CT
Recruiting·—·Phase 1·NCT06062745·30 enrolled
Exploring the Efficacy, Safety of a Modified Starting Dosage of Avatrombopag in Immune Throbocytopenia (ITP) - a Pilot Study
Recruiting·—·Phase 4·NCT07133659·25 enrolled
Pilot Study of RR-HNK in OCD
Recruiting·—·Phase 1/2·NCT06575075·45 enrolled
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Recruiting·—·Phase 1·NCT02637934·35 enrolled
Page 1 of 23
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)